ÂÜÀòÂÒÂ×

Mr. Cohen is an Advisor to Xeraya Capital. He has more 30 years of management, marketing and business development experience in life sciences and high technology companies. Mr. Cohen was the founding President and CEO of three early-stage biotechnology companies: Acacia Biosciences (acquired by Rosetta Inpharmatics), Cellerant Therapeutics and VitaPath Genetics. He served as CFO at GeneSoft Pharmaceuticals and has also held senior positions in business development and marketing at SEQUUS Pharmaceuticals and in the International, Management Services, and Information Technology business units at Baxter International. Mr. Cohen was the President and COO of ViTel International Inc., a pre-internet electronic messaging company. He also served as a management consultant with Monitor Company, working in the healthcare and high technology sectors. He was a member of the founding team of the Tufts Veterinary School and a regional manager of the National Health Professions Placement Network. Mr. Cohen is currently serving as CEO of Prime Biologics, a Xeraya portfolio company. He represents Xeraya on the boards of Chrono Therapeutics and Rapid Micro Biosystems. He holds a BA and an MA from Tufts University, and an MBA with distinction from Harvard Business School.